BRUKINSA vs SIROLIMUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. BRUKINSA and SIROLIMUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BRUKINSA	SIROLIMUS
Rating	New	66/100
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	ZANUBRUTINIB	SIROLIMUS
Manufacturer	Beone Medicines USA	Apotex
Dosage forms	Capsule, Tablet	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Mantle-Cell Lymphoma	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

brukinsa sirolimus

Rating

New

66/100

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

ZANUBRUTINIB

SIROLIMUS

Manufacturer

Beone Medicines USA

Apotex

Dosage forms

Capsule, Tablet

Solution

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Mantle-Cell Lymphoma

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

What is the difference between Brukinsa and Sirolimus?

Brukinsa contains Zanubrutinib, while Sirolimus contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.